Skip to main content
Equibles

Yaron Eldad

CFO

Evogene Ltd. (EVGN)

Equibles does not estimate personal net worth.

Get an email with a short summary when Evogene Ltd. publishes a filing, an earnings call transcript or a press release.

Get EVGN alerts

About Yaron Eldad

Yaron Eldad is recorded as CFO at Evogene Ltd. (EVGN). Yaron Eldad has spoken on 9 earnings calls across 1 company, most recently for Evogene Ltd. on March 5, 2026. Evogene Ltd. is classified in the Biotechnology industry within the Healthcare sector.

Yaron Eldad on recent calls

“As part of the company's updated strategic plan, management implemented an organizational realignment and cost reduction initiatives.”
CFO, Evogene Ltd. Q4 FY2025 Earnings Call ·
“The financial results for the first nine months of 2025 and the capital gain of Lavie Bio, a subsidiary of Evogene, are presented as a single line item in Evogene's consolidated P&L statement for the first nine months of 2025.”
CFO, Evogene Ltd. Q3 FY2025 Earnings Call ·
“As of June 30, 2025, Evogene held consolidated cash, cash equivalents and short-term bank deposits of approximately $11.7 million. The consolidated cash usage during the second quarter of 2025 was approximately $2.4 million.”
CFO, Evogene Ltd. Q2 FY2025 Earnings Call ·
“As of March 31, 2025, Evogene held consolidated cash, cash equivalents, and short-term bank deposits of approximately $9.8 million, compared to approximately $15.3 million as of December 31, 2024.”
CFO, Evogene Ltd. Q1 FY2025 Earnings Call ·
“As of December 31, 2024, Evogene had consolidated cash, cash equivalents, and short-term bank deposits of approximately $15.3 million. The consolidated cash usage during the fourth quarter of 2024 was approximately $4.6 million.”
CFO, Evogene Ltd. Q4 FY2024 Earnings Call ·

Affiliation history

Company network

Recent activity